We provide you with 20 years of free, institutional-grade data for CGEN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CGEN. Explore the full financial landscape of CGEN stock.
| Reported Date | CIK | Ticker | Type |
|---|
Compugen Ltd(NASDAQ:CGEN) 
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody...
Website: http://www.cgen.com
Founded: 1981
Full Time Employees: 61
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about CGEN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.